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Objective: The p53 tumor-suppressor protein p53R2 is activated in response to various stressors that act
on cell signaling. When DNA is damaged, phosphorylation of p53 at its Ser 15 residue induces p53R2
production. The role of p53R2 in chondrocytes remains poorly understood. In this study, we evaluated in
chondrocytes, p53R2 expression and its regulation in response to mechanical stress. Furthermore, we
investigated the function of p53R2 in relation to mechanotransduction.
Methods: Osteoarthritis (OA) cartilage obtained from total knee replacements and normal cartilage ob-
tained from femoral neck fractures was used to measure p53R2 expression by using immunohisto-
chemistry, western blotting, and real-time polymerase chain reaction (PCR). The OA chondrocytes were
subjected to a high magnitude of cyclical tensile strain by using an FX-2000 Flexercell system. Next,
sulfated glycosaminoglycan (sGAG) production was quantiﬁed in these cells. Protein expression of p53R2,
and phosphorylation of Akt, p38MAPK, ERK1/2, and JNK was also detected using western blotting.
Moreover, Akt phosphorylation was detected after transfecting the cells with p53R2-speciﬁc small
interfering RNA (siRNA).
Results: Expression of p53R2 was signiﬁcantly increased in OA chondrocytes and in chondrocytes after
applying 5% tensile strain to the cells. However, Akt phosphorylation was down-regulated in OA chon-
drocytes after the strain, and was up-regulated after transfection of p53R2. sGAG protein as well as
collagen type II and aggrecan mRNA was increased following transfection of p53R2-speciﬁc siRNA after
5% tensile strain.
Conclusions: p53R2 could regulate matrix synthesis via Akt phosphorylation during chondrocyte
mechanotransduction. Down-regulation of p53R2 may be a new therapeutic approach in OA therapy.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
During physical activity, the human joint cartilage is continually
subjected to repetitive mechanical loading that is essential for both
cartilage maintenance and metabolism. Appropriate joint loads
stimulate chondrocytes to maintain healthy cartilage with
a concrete protein composition according to loading demands. In
contrast, inappropriate loads alter the composition of cartilage,
leading to osteoarthritic (OA)1. Mechanical stimuli are known to
affect chondrocyte homeostasis as well as induce anabolic and
catabolic pathways2,3.T. Nishiyama, Department of
l of Medicine, 7-5-2 Kusuno-
-5985; Fax: 81-78-351-6944.
nishiyam@med.kobe-u.ac.jp
s Research Society International. Pp53 has been identiﬁed as a 53-kDa cellular protein and the
ultimate tumor-suppressor gene4. Stresses, both intrinsic and
extrinsic to the cell, can act upon the p53 pathway. Among the
signals that activate the p53 protein is damage to the integrity of
the DNA template. In response to stress signaling, p53 is activated
in a speciﬁc manner by post-translational modiﬁcations, leading to
cell cycle arrest, an event that induces senescence or cellular
apoptosis5. In this way, a variety of intrinsic or extrinsic stresses
that would result in a loss of ﬁdelity in DNA replication, genome
stability, cell cycle progression, or faithful chromosome segregation
can be accommodated, or alternatively, the clone of cells with these
defects can be eliminated from the body.
Chondrocyte apoptosis, a type of programmed cell death, is an
important event in the pathogenesis of OA cartilage degradation6.
We have previously reported that excessive mechanical stress
induces chondrocyte apoptosis via the p53-p53AIP1 (apoptosis-
inducing protein 1) pathway7.ublished by Elsevier Ltd. All rights reserved.
Table I
Primer sequences of genes used for real-time PCR analysis
Gene name Primer sequence (50e30) Primer sequence (30e50)
p53R2 GAGGCTCGCTGTTTCTATGG ATCTGCTATCCATCGCAAGG
COL2A1 CAGGTGAAGGTGGGAAACCA ACCCACGAGGCCAGGAG
Aggrecan TCGAGGACAGCGAGGCC TCGAGGGTGTAGCGTGTAGAGA
GAPDH ATGGGGAAGGTGAAGGTCG TAAAAGCAGCCCTGGTGACC
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p53R2 is directly regulated by p53 during the supply of nucleotides
for the repair of damaged DNA caused by various genotoxic
stresses, including UV light or g-irradiation. DNA synthesis in cells
arrested in the G1 or G2 phase after DNA damage is mediated
through the RR activity of p53R2; the inactivation of p53R2 could
result in the activation of a p53-dependent apoptotic pathway,
eliminating the cells containing un-repaired DNA8. Recently, p53R2
was identiﬁed as not just a DNA supplier, but also an important
transcriptional regulator. p53R2 interacts with MEK2, the extra-
cellular signal-regulated kinase (ERK) kinase 2-mitogen-activated
protein kinase (MAPK) 2, and the molecule immediately upstream
of ERK in the RaseRafeMAPK signaling cascade. p53R2 negatively
modulates serum-induced MEKeERK activity and inhibits the
MEKeERK-mediated malignancy potential of human cancer cells9.
However, the role of p53R2 in chondrocytes remains poorly
understood. In the present study, we examined the regulation of
p53R2 in chondrocytes in response to mechanical stress. In addi-
tion, we examined the hypothesis that p53R2 could regulate
various protein kinases associated with mechanotransduction, and
whether p53R2 regulation could play a role in chondrocyte
metabolism.
Materials and methods
Human cartilage samples
OA cartilage samples were obtained from the femoral condyle of
patients undergoing total knee arthroplasty for primary OA.
Normal cartilage samples were obtained from patients with
femoral neck fractures who were undergoing femoral head
replacement surgeries, and were used as age-matched non-
arthritic articular cartilage samples. The chondrocyte isolation
procedure was carried out after approval from an institutional
review board. Cartilage matrix was digested for 2 h in collagenase
to release the chondrocytes, which were then ﬁltered through
a nylon mesh, collected by centrifugation, and washed twice in
15 mL of PBS. The isolated chondrocytes were subsequently
cultured at 37C and 5% CO2 in 15mL of Dulbecco’s Modiﬁed Eagle’s
Medium (DMEM; GIBCO-BRL, Grand Island, NY) containing 10%
fetal bovine serum (FBS; BioWhittaker, Walkersville, MD) and
100 units/mL of penicillinestreptomycin.
All samples were obtained in accordance with the World
Medical Association Declaration of Helsinki Ethical Principles for
Medical Research Involving Human Subjects. The study was
approved by our institutional review board, and all patients
provided written informed consent. In order to ﬁgure out the
chondrocytes characterization, we conﬁrmed that type II collagen
was expressed higher in normal human hip chondrocytes than in
OA knee chondrocytes, and type X collagenwas expressed higher in
OA knee chondrocytes than in normal hip chondrocytes.
Immunohistochemistry
For immunohistochemical analysis of p53R2, deparafﬁnized
sections were digested with proteinase (Dako, Glostrup, Denmark)
for 10 min, and then treated with 3% hydrogen peroxide (Wako
Pure Chemical Industries, Osaka, Japan) to block endogenous
peroxidase activity. Next, the sections were incubated with anti-
human p53R2 primary antibodies (1:50 dilution; Santa Cruz
Biotechnology, Santa Cruz, CA) overnight at 4C, and subsequently
incubated with peroxidase-labeled anti-goat immunoglobulin
(Histoﬁne Simple Stain MAX PO (R); Nichirei Bioscience, Tokyo,
Japan) at room temperature for 30 min. The signal was developed
as a brown reaction product by using the peroxidase substrate3,30-diaminobenzidine (Histoﬁne Simple Stain DAB Solution,
Nichirei Bioscience), and the sections were microscopically exam-
ined. The numbers of p53R2 stained cell were counted in three
areas of highmagniﬁcation ﬁelds at both superﬁcial and deep zones
of cartilage tissue by individual three blinded observers.
Western blot analysis
Chondrocytes were washed three times in PBS, and then lysed
for 20 min on ice in MOPS buffer (25 mM Tris, 1% Nonidet P40,
150 mM NaCl, and 1.5 mM EGTA) supplemented with protease and
phosphatase inhibitor mix (Roche Diagnostics, Basel, Switzerland).
The lysates were centrifuged at 15,000 rpm for 20 min to remove
cellular debris, and the supernatants were collected. The concen-
tration of proteins was quantiﬁed by the Bradford method
with protein assay reagent (Bio-Rad), and diluted to an equal
concentration with hypotonic buffer. Each sample was mixed
with 3 electrophoresis sample buffer and electrophoresed on a
7.5%e15% polyacrylamide gradient gel (Biocraft, Tokyo, Japan) and
electrically transblotted onto a blotting membrane (GE Healthcare,
Buckinghamshire, UK). Anti-human p53R2 polyclonal antibody
(SantaCruz Biotechnology, Santa Cruz, CA), anti-humanmonoclonal
phospho-p53 (Ser 15/46), anti-humanpolyclonal phospho-Akt, Akt,
phospho-ERK, ERK, phospho-p38MAPK, p38MAPK, phospho-JNK,
and JNK (Cell Signaling Technology, Beverly, MA) were used as
primary antibodies. Horseradish peroxidase (HRP)-conjugated goat
anti-rabbit immunoglobulin G antibody (IgG Ab, GE Healthcare)
and HRP-conjugated rabbit anti-mouse IgG Ab (GE Healthcare)
were used as secondary antibodies, and the signals were visualized
using ECL plus reagent (GE Healthcare) in a Chemilumino analyzer
LAS-3000 mini (FUJI FILM, Tokyo, Japan).
Real-time polymerase chain reaction (PCR) analysis of chondrocytes
Chondrocytes were cultured in six-well plates with various
stimulants, and total RNA was extracted using a QIAshredder and
RNeasy Mini kit, according to the recommendations of the manu-
facturer (Qiagen, Hilden, Germany). Total RNA (1 mg) was reverse
transcribed to ﬁrst-strand complementary DNA (cDNA) by using
High-capacity cDNA transcription kits, according to the manufac-
turer’s protocol (Applied Biosystems, Foster City, CA). Real-time
PCR was performed using an ABI prism 7700 sequence detection
system (Applied Biosystems). Real-time validation was carried out
using the 2DDCt method. The speciﬁc primer design sets used are
described in Table I. Gene expression cycle threshold values were
normalized to the expression of the housekeeping gene GAPDH.
Culture of OA human knee chondrocytes and exposure to
mechanical stress
Human OA chondrocytes obtained from total knee arthroplasty
were cultured in a humidiﬁed atmosphere of 5% CO2 and 95% air at
37C in a “Bullet Kit”. Cells were grown to a subconﬂuent state, and
thenplated onto six-well plates at a density of 3105 cells perwell in
DMEM/F-12 medium supplemented with 10% FBS and 100 U/mL of
penicillinestreptomycin. In a separate experiment, cells were grown
to a subconﬂuent state, and then plated onto type I collagen-coated
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a density of 3  105 cells per well in DMEM/F-12 medium supple-
mentedwith10%FBSand100U/mLofpenicillinestreptomycin.Cyclic
tensile strain experiments were performed using an FX-2000 Flex-
ercell system (Flexcell International, McKeesport, PA). Tensile strain
was enforced at 2%, 5%, and 10% elongation (0.25 Hz) for 12 h.
Small interfering RNA (siRNA) transfection
The p53R2 siRNA (human) assay was obtained from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). Brieﬂy, 3  105 cells were
seeded per well in six-well culture plates ﬁlled with 2 mL of
antibiotic-free DMEM/F-12 medium supplemented with 10% FBS,
and then incubated for 24 h at 37C and 5% CO2. Cells were
subsequently incubated in transfection medium for 24 h, and then
switched to serum-free DMEM medium.
Glycosaminoglycan quantiﬁcation
To measure sulfated glycosaminoglycan (sGAG) release, we
collected culture medium from OA chondrocytes transfected with
p53R2-speciﬁc siRNAor control siRNA after applying 5% tensile strain
for 12 h. The concentration of sGAG was measured using a sGAG
quantitative kit, according to the manufacturer’s protocol (Wieslab,
Nijmegen, Netherland), and normalized to total protein per cell.
Statistical analysis
Data are expressed as themean 95% conﬁdence intervals (CIs).
For normally distributed data, one-way analysis of variance withFig. 1. Immunohistochemistry for p53R2 in normal and osteoarthritic (OA) cartilage tissue. T
in normal and OA cartilage. (A) Expression of p53R2 in normal and OA chondrocytes, as det
examined by real-time PCR. (C) Each sample was derived from different individuals.Tukey’s post-hoc test was used for multiple comparisons of paired
samples. The ManneWhitney U test was used for comparisons
between two groups. All tests were performed using statistical
software Statcel2 (O.M.S. publishing, Tokorozawa, Japan). A P value
of <0.05 was considered signiﬁcant for all analyses.
Results
In situ immunoﬂuorescence staining of the p53R2 in human
cartilage
Weﬁrstexaminedp53R2expression innormal andOAcartilageby
using immunoﬂuorescence staining. Immunohistological analysis
showed that p53R2 was strongly and ubiquitously expressed in OA
cartilage, but not in normal cartilage [Fig. 1(A)]. The average
percentages of p53R2 positive cells/total cells were calculated. The
percentage of P53R2 positive cells at both superﬁcial and deep zone
wassigniﬁcantly increased inOAcartilage [Fig.1(A)] (superﬁcial zone;
normalmean¼21.3%95%CI4.53e38.0N¼4,OAmean¼73.5%95%CI
62.1e84.8N¼ 4) (deep zone; normalmean¼ 32.3% 95% CI 21.3e43.4
N ¼ 4, OA mean ¼ 75.9% 95% CI 62.7e89.1 N ¼ 4).
p53R2 protein and mRNA expression in chondrocytes from normal
and OA human articular cartilage
Western blotting analyses showed that p53R2 protein was
expressed in both normal and OA chondrocytes. However, the
expression of p53R2 proteinwas higher in OA chondrocytes than in
normal chondrocytes [Fig. 1(B)]. Real-time PCR showed that p53R2
mRNA expression in OA chondrocytes was about 10-folds higherhe dot plots graph show percentage of p53R2 positive cells at superﬁcial and deep zone
ected by western blotting. (B) Expression of p53R2 in normal and OA chondrocytes, as
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CI 0.459 to 2.459 N ¼ 3, OA mean ¼ 10.8 95% CI 11.099 to 32.775
N ¼ 5).
p53R2 expression in OA chondrocytes was up-regulated after
applying 5% tensile strain
We examined the expression of p53R2 in OA chondrocytes after
applying various magnitudes of tensile strain to the cells. Western
blotting showed that the expression of p53R2 was up-regulated
after applying 5% tensile strain, but it was not so much up-
regulated after applying 10% strain as 5% strain [Fig. 2(A)]. Real-
time PCR conﬁrmed that p53R2 was up-regulated after applying
5% tensile strain [Fig. 2(B)] (0%; N ¼ 10 mean ¼ 1.16 95% CI
0.75e1.58 2%; N ¼ 6, mean ¼ 2.94 95% CI 0.59e5.30 5%; N ¼ 7,
mean ¼ 4.75 95% CI 3.55e5.94 10%; N ¼ 4, mean ¼ 2.41 95%
CI 0.53 to 5.35).
Phosphorylation of p53 at Ser 15 was increased after applying
5% tensile strain compared with the non-loaded controls [Fig. 2(B)].
However, phosphorylation of p53 at Ser 46 was not changed
[Fig. 2(C)]. These results demonstrated that p53R2 was up-
regulated via phosphorylation of p53 at Ser 15 after application of
5% tensile strain.
Inhibition of p53R2 increased sGAG, COL2A1, and aggrecan
expression after applying 5% tensile strain
To determine the role of p53R2 in chondrocyte matrix metab-
olism, endogenous p53R2 expression was reduced by the incuba-
tion of the OA chondrocytes with siRNA speciﬁc for p53R2 mRNA.
We tested the expression levels of type II collagen (COL2A1) and
aggrecan mRNA after applying 5% tensile strain for 12 h. Further-
more, sGAG concentrations in the culture medium supernatant
were quantiﬁed after applying 5% tensile strain. Down-regulation
of p53R2 mRNA expression signiﬁcantly increased COL2A1Fig. 2. Expression of p53R2 in OA chondrocytes after applying various magnitudes (2%, 5%, a
PCR (B). Each sample was derived from different individuals. Phosphorylation of p53 at Ser(control siRNA mean ¼ 1.05 95% CI 0.574e1.536 N ¼ 5) (p53 siRNA
mean ¼ 2.64 95% CI 0.167e5.123 N ¼ 5) and aggrecan (control
siRNA mean ¼ 1.02 95% CI 0.124e1.921 N ¼ 5; p53R2 siRNA
mean ¼ 2.98 95% CI 1.097e4.869 N ¼ 5) expression after applying
5% tensile strain [Fig. 3(A)]. Moreover, sGAG production per cell was
increased by the down-regulation of p53R2 expression [Fig. 3(B)]
(control siRNA mean¼ 1.15 95% CI 1.013e1.293 N ¼ 4; p53R2 siRNA
mean ¼ 1.43 95% CI 1.107e1.769 N ¼ 4).
Regulation of protein kinases in normal and OA chondrocytes after
5% tensile strain
To investigate whether p53R2 has a role in mechano-
transduction, we examined the expression of the following protein
kinases: phospho-Akt, Akt, phospho-ERK1/2, ERK1/2, phospho-
p38MAPK, p38MAPK, phospho-JNK, and JNK. Whereas the phos-
phorylation of p38MAPK, ERK, and JNK remained unchanged
relative to the non-loaded controls after applying 5% tensile strain,
Akt phosphorylation was down-regulated under the same condi-
tions [Fig. 4(A)].
Inhibition of p53R2 up-regulated Akt phosphorylation after tensile
strain
Western blotting showed that inhibition of p53R2 via p53R2-
speciﬁc siRNA transfection positively regulated Akt phosphoryla-
tion after applying 5% tensile strain [Fig. 4(B)].
Discussion
The results obtained in this study demonstrate for the ﬁrst time,
to the best of our knowledge, that adult human chondrocytes
express p53R2 both in situ in the articular cartilage and in vitro after
isolation and culture. Interestingly, we found that p53R2 expression
was barely detectable in normal cartilage, but clearly expressed inOAnd 10%) of tensile strain for 12 h was detected using western blotting (A) and real-time
15 and Ser 46 in OA chondrocytes was observed after applying 5% tensile strain (C).
Fig. 3. COL2A1 and aggrecan expression of OA chondrocytes after p53R2 siRNA and control siRNA transfection. (A) sGAG was quantiﬁed after transfection of the cells with p53R2
siRNA or control siRNA. (B) Each sample was derived from different individuals.
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positively correlated with cartilage degeneration, and p53R2 played
a role in the pathogenesis of OA. Mechanical stress is one of the
factors believed to be involved in the onset and progression of OA.
We hypothesized that p53R2 was regulated by mechanical stress
and was associated with mechanotransduction in cartilage. Thus,
we investigated p53R2 expression in chondrocytes after various
magnitudes of tensile strain. The results showed that p53R2
expression was up-regulated after applying 5% tensile strain.
During normal movements in vivo, articular chondrocytes were
exposed compression loads of 15%, which leads to 5% tensile strain
in chondrocytes10. Chondrocytes are directly exposed compression
force during the loading of intact cartilage, it is very likely that
collagen and other matrix components of the extracellular matrix
interaction that are linked to the chondrocytes stretch the cells
during cartilage compression11. Low-magnitude mechanical strain
caused up-regulation of proteoglycan and type II collagen
synthesis12e14. In contrast, high-magnitude mechanical strain
caused cartilage destruction while inhibiting matrix synthesis15.Fig. 4. Phospho-Akt, Akt, phospho-p38MAPK, p38MAPK, phospho-ERK, ERK, phospho-JNK
blotting (A). p53R2, phospho-Akt, and Akt expression was observed in OA chondrocytes aftWe previously demonstrated that chondrocyte DNA was
damaged, and p53AIP1was induced leading to apoptosis, when 10%
tensile strain was applied to human chondrocytes. p53 is a tran-
scription factor that maintains the integrity of the genome in
response to the DNA damage-inducing genes involved in cell cycle
arrest, DNA repair, or cell death5. The p53 tumor-suppressor gene
p53R2 controls cellular response to DNA damage, and forms
a critical link to the downstream effectors of growth arrest or cell
death. When DNA is damaged so severely as to be non-reparable,
p53 is phosphorylated at Ser 46, which stimulates p53AIP1
production, leading to apoptosis16,17. In contrast, in the early stage
of p53 activation after DNA damage, its phosphorylation at Ser 15
and some other sites occurs, which, in turn, promotes binding of
p53 to the promoters of cell cycle arrest genes, DNA repair genes,
and other genes such as p21waf1/cip1 and p53R216. The p53R2
regulatory subunit of ribonucleotide reductase (RNR) is directly
induced by p53 and functions as a catalytic partner of the regula-
tory subunit R1 to supply nucleotides for DNA repair14. Triggered by
DNA damage, it operates during the G1 or G2 phase8., JNK and p53R2 expression after applying 5% tensile strain, as detected by western
er p53R2 inhibition (B).
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cartilage and up-regulated after applying 5% tensile stain in this
study. The expression of p53R2 is regulated by phosphorylation of
p53 at Ser 15. The phosphorylation of p53 at Ser 15 was increased
by 5% tensile strain in comparisonwith 10% strain (data not shown).
Therefore, p53R2 expression was increased at 5% stress in
comparison with 2 or 10% stress. While, in physiological circum-
stance, 5% tensile strain is exposed to chondrocytes. Therefore,
p53R2 may be up-regulated in both normal and OA cartilage tissue
during normal joint movement in comparison with non-stress
circumstance. However, p53R2 also plays DNA repair in response
to DNA damage such as OA joint circumstance. We previously have
shown that DNA damage was increased in OA cartilage than in
normal cartilage7. Therefore, the expressions of p53R2 in OA
chondrocytes were increased in comparison with normal
chondrocytes.
Recent studies revealed that the p53 pathway modulates the
insulin-like growth factor-1 (IGF-1)/Akt and the mammalian target
of rapamycin (mTOR) pathways; in response to stress, the p53
pathway negatively regulates the IGF-1/AKT and mTOR pathways
to shut down cell growth and division, thus preventing the intro-
duction of inﬁdelity into the process of cell growth and division18,19.
In our study, phospho-Akt was down-regulated after applying
5% tensile strain. To elucidate the role of p53R2, we investigated the
effect of p53R2 inhibition on Akt phosphorylation. The inhibition of
p53R2 induced marked up-regulation of Akt phosphorylation.
These results demonstrate for the ﬁrst time, to the best of our
knowledge, that p53R2 is one of the proteins transcribed by p53,
which negatively regulates Akt phosphorylation in chondrocytes.
Several studies have shown that the protein kinase Akt is
involved in mechanotransduction, and that Akt-dependent signal
transduction pathways are activated by phosphorylation in
a variety of tissues after mechanical loading20e23.
In adult articular cartilage, PI-3 kinase-Akt signaling promotes
matrix synthesis as well as the survival of chondrocytes. Expression
of constitutively active Akt in human articular chondrocytes
resulted in signiﬁcant increases in proteoglycan synthesis, type II
collagen synthesis and expression, as well as Sox9 expression.
Inhibition of PI-3 kinase-Akt signaling has been shown to inhibit
chondrocyte proteoglycan synthesis and reduce chondrocyte
survival24e26.
We have demonstrated in this study that p53R2 inhibition
increased proteoglycan synthesis and Col2A1 and aggrecan mRNA
expression after applying 5% tensile strain. Therefore, we concluded
that p53R2 inhibition caused an anabolic response in the chon-
drocytes via Akt-dependent mechanotransduction after mechan-
ical stress.
In summary, we observed that p53R2 expression was increased
in OA cartilage and up-regulated after applying 5% tensile stain. In
addition, p53R2 inhibition increased matrix synthesis via Akt
phosphorylation. These observations suggest that the expression of
p53R2 may be increased with the development of OA, and down-
regulation of p53R2 might have an anabolic effect on human
chondrocytes. Further analysis of p53R2 will provide novel insights
into the pathogenesis of OA and new therapeutic approaches for
treating OA patients.
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